CGS-authored

SAN FRANCISCO, April 10 _ California's program to study embryonic stem cells awarded its first round of grants Monday, drawing on money put up by state business leaders trying to move the program forward despite legal challenges.

The program is in limbo because of lawsuits by opponents of embryonic stem cell research who challenge its constitutionality. As a result, it has been prevented from distributing any of the $3 billion in bonds approved by voters in 2004.

Instead, officials have sold $14 million in so-called bond anticipation notes. They awarded $12.1 million of that money on Monday.

The grants were given to 16 California nonprofit research institutions to train what program officials have called the next generation of stem cell researchers. The program, the California Institute for Regenerative Medicine, is raising an additional $32 million in bond anticipation notes, its chairman, Robert N. Klein, has said.

The grant recipients include stem cell research trainees at Stanford, numerous University of California campuses and the Salk Institute of Biological Studies. The grants range from $347,160 to $1.23 million.

The bonds, approved by...